secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ribbon Acquisition Corp. (RIBB)
CIK:        0002035016
Form:       8-K
Filed at:   2026-09-11T20:03:12+00:00
Accession:  0001213900-26-099253
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ribbon Acquisition shareholders approve DRC Medicine deal; heavy redemptions leave $1.4M trust
--------------------------------------------------------------------------------

- All 8 proposals passed, including Business Combination with DRC Medicine Ltd. (2,835,534 for, 371,112 against).
- Domestication to Delaware approved; also Charter NTA amendment, Nasdaq issuance, Incentive Plan, director elections.
- Redemptions: 3,460,471 shares tendered; after 30,633 reversals, 3,429,838 remain subject to redemption (~$36,321,984.42).
- Trust account balance after redemptions ~$1,411,594.05; per-share redemption price ~$10.59.
- Seven Pubco directors elected, including Narumi Okazaki, Akira Okada, Shigeo Kamitsuji, etc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2035016/000121390026099253/0001213900-26-099253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2035016/000121390026099253/ea0305127-8k_ribbon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-099253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer